Global Rare Disease Diagnostics Market to Reach $70.69 Billion by 2030
Rare disease diagnostics by whole genome and exome sequencing are disruptive technological developments in the healthcare industry, which have paved the path for the development of several breakthrough treatments and procedures aimed to address the primary concerns for global health.
Read More